Abstract
The interaction between the adenomatous polyposis coli (APC) tumour suppressor and the microtubule-associated protein EB1 was examined. Immunoprecipitation suggested that APC and EB1 were not associated in cultures of HCT116 cells arrested in mitosis. The C-terminal 170 amino acids of APC, purified as a bacterial fusion protein, precipitated EB1 from cell extracts, significantly refining the location of the EB1 interaction domain in APC. In vitro phosphorylation of this fusion protein by either protein kinase A or p34cdc2 reduced its ability to bind to EB1. Expression of GFP fusions to C-terminal APC sequences lacking or including the APC basic domain but encompassing the EB1 binding region in SW480 cells revealed a microtubule tip association which co-localized with that of EB1. Expression of the basic domain alone revealed a non-specific microtubule localization. In vitro interaction studies confirmed that the APC basic domain did not contribute to EB1 binding. These findings strongly suggest that the interaction between APC and EB1 targets APC to microtubule tips, and that the interaction between the two proteins is down-regulated during mitosis by the previously described mitotic phosphorylation of APC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- APC:
-
adenomatous polyposis coli
- GST:
-
glutathione-S-transferase
- DTT:
-
dithiothreitol
- PBS:
-
phosphate buffered saline
- PCR:
-
polymerase chain reaction
- TX100:
-
Triton X-100
- AS:
-
asynchronous
- M:
-
mitosis
- PKA:
-
protein kinase A
- PKC:
-
protein kinase C
- CKII:
-
casein kinase II
- eGFP:
-
enhanced green fluorescent protein
References
Alfa CE, Ducommun B, Beach D and Hyams JS . 1990 Nature 347: 680–682
Andreassen PR and Margolis RL . 1994 J Cell Biol 127: 789–802
Beinhauer JD, Hagan IM, Hegemann JH and Fleig U . 1997 J Cell Biol 139: 717–728
Berrueta L, Kraeft S-K, Tirnauer JS, Schuyler SC, Chen LB, Hill DE, Pellman D and Bierer BE . 1998 Proc Natl Acad Sci USA 95: 10596–10601
Berrueta L, Tirnauer JS, Schuyler SC, Pellman D and Bierer BE . 1999 Curr Biol 9: 425–428
Cassimeris L . 1999 Curr Opin Cell Biol 11: 134–141
Deka J, Kuhlmann J and Muller O . 1998 Eur J Biochem 253: 591–597
Illenberger S, Zheng-Fischhoffer Q, Preuss U, Stamer K, Baumann K, Trinczek B, Biernat J, Godeman R, Mandelkow E-M and Mandelkow E . 1998 Mol Biol Cell 9: 1495–1512
Juwana J-P, Henderikx P, Mischo A, Wadle A, Fadle N, Gerlock K, Arends JW, Hoogenboom H, Pfreundschuh M and Renner C . 1999 Int J Cancer 81: 275–284
Lengauer C, Kinzler KW and Vogelstein B . 1997 Nature 386: 623–627
Morin PJ, Vogelstein B and Kinzler KW . 1996 Proc Natl Acad Sci USA 93: 7950–7954
Morrison EE, Askham J, Clissold P, Markham AF and Meredith DM . 1997 Neuroscience 81: 553–567
Morrison EE, Wardleworth B, Askham J, Markham AF and Meredith DM . 1998a Oncogene 17: 3471–3477
Morrison EE, Wang Y-F and Meredith DM . 1998b J Virol 72: 7108–7114
Muha L, Adames NR, Murphy MD, Shields CR and Cooper JA . 1998 Nature 393: 487–491
Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B and Polakis P . 1994 Cancer Res 54: 3676–3681
Näthke IS, Adams CL, Polakis P, Sellin JH and Nelson JW . 1996 J Cell Biol 134: 165–179
Oshima M, Oshima H, Kitagawa A, Kobayashi M, Itakura C and Taketo M . 1995 Proc Natl Acad Sci USA 92: 4482–4486
Pollock AL, Barth AIM, Altschuler Y, Nelson WJ and Mostov KE . 1997 J Cell Biol 137: 1651–1662
Schwartz K, Richards K and Botstein D . 1997 Mol Biol Cell 8: 2677–2691
Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B and Kinzler KW . 1994 Cancer Res 54: 3672–3675
Su L-K, Burrell M, Hill DE, Gyuris J, Brent R, Wiltshire R, Trent J, Vogelstein B and Kinzler KW . 1995 Cancer Res 55: 2972–2977
Trzepacz C, Lowy AM, Kordich JJ and Groden J . 1997 J Biol Chem 272: 21681–21684
Wong MH, Hermiston ML, Syder AJ and Gordon JI . 1996 Proc Natl Acad Sci USA 93: 9588–9593
Acknowledgements
This work was supported by grants from the Medical Research Council (UK), Yorkshire Cancer Research and the West Riding Medical Research Trust.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Askham, J., Moncur, P., Markham, A. et al. Regulation and function of the interaction between the APC tumour suppressor protein and EB1. Oncogene 19, 1950–1958 (2000). https://doi.org/10.1038/sj.onc.1203498
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203498
Keywords
This article is cited by
-
Tumour Suppressor Adenomatous Polyposis Coli (APC) localisation is regulated by both Kinesin-1 and Kinesin-2
Scientific Reports (2016)
-
Human ASPM participates in spindle organisation, spindle orientation and cytokinesis
BMC Cell Biology (2010)
-
Detecting variable (V), diversity (D) and joining (J) gene segment recombination using a two-colour fluorescence system
Mobile DNA (2010)
-
MCAK associates with EB1
Oncogene (2008)
-
The adenomatous polyposis coli tumor suppressor protein and microtubule dynamics
Current Colorectal Cancer Reports (2007)